J Neuroinflammation
Research Dose Ranges Preclinical animal studies: 110 mcg/kg (nanogram to microgram range) once or twice daily Extrapolated human equivalent range commonly discussed in clinical literature: 200500 mcg/day Human pilot IV data: doses up to 20 mg were tolerated without adverse effects in two healthy adults (Lee & Burgess, 2025) though this is far above typical outpatient dosing Protocol: Musculoskeletal / Connective Tissue Healing For tendon, ligament, or muscle injury recovery, the standard approach in clinical functional medicine practice involves: SubQ injection at 200500 mcg once daily , injected near (not into) the injury site Cycle length: typically 48 weeks , with reassessment Often combined with TB-500 (thymosin beta-4) for synergistic tissue remodeling the BPC+TB stack Best results seen alongside physical therapy, not as a substitute for it Protocol: Gut and GI Mucosal Healing For IBD, gut permeability, NSAID damage, or H
ulcerative colitis relief via SIRT1/STAT3 pathway.[6] Connectivity Map Gene-Signature Profiling A research workflow used in oncology and aging laboratories applies the Broad Institute's Connectivity Map (CMAP) to interrogate which transcriptional states GHK can reverse
Yet, as with any ingredient that we put into the body, it is best not to go above extreme thresholds of vitamin B12 intake
The ongoing nature of chemical injury makes these wounds particularly difficult to treat
